F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) Short Interest Update

F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) was the target of a large decline in short interest in July. As of July 31st, there was short interest totaling 11,453 shares, a decline of 48.0% from the July 15th total of 22,041 shares. Approximately 0.4% of the company’s shares are short sold. Based on an average daily volume of 4,707 shares, the short-interest ratio is presently 2.4 days.

F/m Emerald Life Sciences Innovation ETF Trading Up 0.3%

LFSC stock traded up $0.13 during midday trading on Tuesday, reaching $47.55. 2,921 shares of the company’s stock traded hands, compared to its average volume of 4,721. F/m Emerald Life Sciences Innovation ETF has a fifty-two week low of $26.75 and a fifty-two week high of $47.68. The business has a 50-day moving average price of $44.76 and a two-hundred day moving average price of $39.37.

Institutional Trading of F/m Emerald Life Sciences Innovation ETF

A hedge fund recently raised its position in F/m Emerald Life Sciences Innovation ETF stock. Hunter Associates Investment Management LLC grew its stake in shares of F/m Emerald Life Sciences Innovation ETF (NASDAQ:LFSC) by 8.3% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 49,739 shares of the company’s stock after purchasing an additional 3,831 shares during the quarter. Hunter Associates Investment Management LLC owned 1.86% of F/m Emerald Life Sciences Innovation ETF worth $1,736,000 at the end of the most recent quarter.

F/m Emerald Life Sciences Innovation ETF Company Profile

The F/M Emerald Life Sciences Innovation ETF (LFSC) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed ETF that targets US health care and biotechnology companies identified to have promising life sciences opportunities. LFSC was launched on Oct 31, 2024 and is issued by F/m Investments.